ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Discovery of YH677 as a cancer stemness inhibitor that suppresses triple-negative breast cancer growth and metastasis by regulating the TGF? signaling pathway

Zhang, Yuzhu; Chen, Jing; Mi, Dazhao; Ling, Jun; Li, Huachao; He, Peng; Liu, Ning; Chen, Qianjun*; Chen, Yihua*; Huang, Luqi*广东省人民医院
Cancer Letters2023-4-28DOI: 10.1016/j.canlet.2023.216142
3被引12阅读
引用收藏
分享

摘要

Triple-negative breast cancer (TNBC) has a poor prognosis due to the lack of specific and highly effective therapeutic agents. Cancer stem cells (CSCs) are one of the main factors contributing to TNBC relapse and metastasis. Therefore, targeting CSCs selectively with small molecules is a novel strategy for drug development. In this study, the natural product harmine (HM) was identified as a hit compound from 2632 natural product monomers based on phenotypic screening of a 2D assay and patient-derived organoid (PDO) model that was established from a patient who had multiple drug resistance and various visceral and contralateral breast metastases. Next, harmine was further modified and optimized to obtain a lead compound (YH677) with a tetrahydro-beta-carboline scaffold. YH677 showed potent antiproliferative and antimigratory activities against several TNBC cell lines in vitro. In addition, YH677 inhibited epithelial mesenchymal transition (EMT) and stem cell marker expression in a dose-dependent manner. More importantly, YH677 suppressed breast cancer growth and metastasis in orthotopic, metastatic xenograft and patient-derived xenograft (PDX) models in vivo. Mechanistic studies showed that YH677 inhibits the expansion of CSCs by regulating the TGF beta/Smad signaling pathway. These preclinical data provide a basis for the development of YH677 as a lead compound for TNBC treatment.

学科与关键词

关键词
Cancer stem cellsTriple-negative breast cancerHarminePatient-derived organoidsTGF ? receptor 1 inhibitor
相关
加载中…
  • Discovery of YH677 as a cancer stemness inhibitor that suppresses triple-negative breast cancer growth and metastasis by regulating the TGFβ signaling pathway (vol 560, 216142, 2023)
    Zhang, Yuzhu; Chen, Jing; Mi, Dazhao; Ling, Jun; Li, Huachao; He, Peng; Liu, Ning; Chen, Qianjun*; Chen, Yihua*; Huang, Luqi*Cancer Letters, 2023, 567: 216195.
  • Inhibition of growth and metastasis of triple-negative breast cancer targeted by Traditional Chinese Medicine Tubeimu in orthotopic mice models.
    Wang, Jingxiao; Yang, Xinjie; Han, Haibo; Wang, Limin; Bao, Weiqian; Wang, Shanshan; Hoffman, Robert M; Yang, Meng; Qi, Hui; An, Chao; Hu, KaiwenChin J Cancer Res, 2018, 30(1): 112-121.
  • Akt3 promotes cancer stemness in triple-negative breast cancer through YB1-Snail/Slug signaling axis
    Tian, Ye; Li, Jiang; Cheung, Tsz Chung; Tam, Vincent; Lau, C. Geoffrey; Wang, Xin; Chin, Y. Rebecca*Genes & Diseases, 2023, 10(2): 301-306.被引 1
查看全部 →

发表信息

论文状态
公开发表
期刊
Cancer Letters
发表日期
2023-04-28
卷期
第 560 卷
页码
216142
DOI
10.1016/j.canlet.2023.216142
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81904206, 82060663, 82260716]; Key project at central government level: The ability establishment of sustainable use for valuable Chinese medicine resources [2060302]

作者

  • Z

    Zhang, Yuzhu (第一作者)

    guangdong prov hosp

  • C

    Chen, Jing

    ningxia med univ

查看全部 10 位作者收起作者
  • M

    Mi, Dazhao

  • L

    Ling, Jun

    ningxia med univ

  • L

    Li, Huachao

    guangdong prov hosp

  • H

    He, Peng

  • L

    Liu, Ning

  • C

    Chen, Qianjun (通讯)

    guangdong prov hosp

  • C

    Chen, Yihua (通讯)

  • H

    Huang, Luqi (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417